Detalhe da pesquisa
1.
Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.
Breast J
; 26(9): 1659-1666, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32713113
2.
Survival according to the site of metastasis in triple-negative breast cancer patients: The Peruvian experience.
PLoS One
; 19(2): e0293833, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300959
3.
Subpopulation treatment effect pattern plot analysis: a prognostic model for distant recurrence-free survival to estimate delayed adjuvant chemotherapy initiation effect in triple-negative breast cancer.
Front Oncol
; 13: 1193927, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38023174
4.
A nationwide pilot study on breast cancer screening in Peru.
Ecancermedicalscience
; 17: 1494, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36816782
5.
Breast cancer subtype and clinical characteristics in women from Peru.
Front Oncol
; 13: 938042, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36925912
6.
Status of breast cancer in Latin American: Results of the breast cancer revealed initiative.
Crit Rev Oncol Hematol
; 181: 103890, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36462594
7.
Immunotherapy in triple-negative breast cancer: A literature review and new advances.
World J Clin Oncol
; 13(3): 219-236, 2022 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35433291
8.
Association between Ancestry-Specific 6q25 Variants and Breast Cancer Subtypes in Peruvian Women.
Cancer Epidemiol Biomarkers Prev
; 31(8): 1602-1609, 2022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35654312
9.
Renal liposarcoma: case report and review of systemic treatment.
Ecancermedicalscience
; 15: 1173, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33680087
10.
PIK3CA mutation in non-metastatic triple-negative breast cancer as a potential biomarker of early relapse: A case report.
World J Clin Oncol
; 12(8): 702-711, 2021 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34513603
11.
Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer.
Clin Breast Cancer
; 21(3): 239-246.e4, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33221201
12.
Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer.
PLoS One
; 15(12): e0243447, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33284847
13.
Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience.
PLoS One
; 15(8): e0237811, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32833983
14.
Breast-conserving surgery vs. total mastectomy in patients with triple negative breast cancer in early stages: A propensity score analysis.
Breast Dis
; 39(1): 29-35, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31903977
15.
Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Is Associated with Indigenous American Ancestry in Latin American Women.
Cancer Res
; 80(9): 1893-1901, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32245796
16.
Barriers in Latin America for the management of locally advanced breast cancer.
Ecancermedicalscience
; 13: 897, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30792814
17.
[Anemia as a prognostic factor in cancer patients]. / Anemia como factor pronóstico en pacientes con cáncer.
Rev Peru Med Exp Salud Publica
; 35(2): 250-258, 2018.
Artigo
em Espanhol
| MEDLINE | ID: mdl-30183919
18.
[Optimal cytoreduction in advanced ovarian cancer treated with dose-dense paclitaxel and carboplatin followed by interval surgery at the Peruvian National Institute of Neoplastic Diseases]. / Citorreducción óptima en cáncer de ovario avanzado tratado con paclitaxel a dosis densa y carboplatino seguido de cirugía de intervalo en el Instituto Nacional de Enfermedades Neoplásicas del Perú.
Rev Peru Med Exp Salud Publica
; 35(1): 46-54, 2018.
Artigo
em Espanhol
| MEDLINE | ID: mdl-29924276
19.
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer.
Sci Rep
; 8(1): 4899, 2018 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29559701
20.
Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
ESMO Open
; 3(3): e000344, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29682332